Document Detail


Aortic root replacement using a biovalsalva prosthesis in comparison to a "handsewn" composite bioprosthesis.
MedLine Citation:
PMID:  20202036     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
BACKGROUND: The Biovalsalva aortic root prosthesis incorporates an Elan porcine stentless biological aortic valve suspended within a triple-layered vascular conduit with preformed aortic sinuses of Valsalva. This study compared implantation of the Biovalsalva prosthesis with a "handsewn" composite bioprosthetic graft (CE Perimount bovine bioprosthesis anastomosed to a gelatin-impregnated gelweave Dacron graft).
METHODS: Between December 2004 and January 2009, 39 patients underwent elective or urgent aortic root replacement (modified Bentall procedure with coronary button reimplantation) using a Biovalsalva (n = 21) or a handsewn bioprosthesis (n = 18) for aortic root dilatation.
RESULTS: There was no significant difference in the preoperative variables between the two study groups including age (70.7 +/- 1.7 vs. 67.6 +/- 2.9 years, p > 0.05). There was no in-hospital mortality. Three patients in each group underwent concomitant aortic hemi-arch replacement. Patients who underwent Biovalsalva implantation had a reduced need for transfusion of blood (1.25 +/- 0.32 vs. 3.17 +/- 0.71 units, p < 0.05) and fresh frozen plasma (2.78 +/- 0.39 vs. 1.85 +/- 0.31, p < 0.05), and reduced mediastinal blood loss (416 +/- 52 vs. 583 +/- 74 mL, p < 0.05) compared to those with a handsewn bioprosthesis. Cardiopulmonary bypass time (141 +/- 6 vs. 170 +/- 17 minutes, p = NS) and aortic cross-clamp time (113 +/- 6 vs. 115 +/- 7 minutes, p = NS) were similar. Postoperative echocardiography demonstrated excellent hemodynamic function of the Biovalsalva prosthesis (mean size 25.1 +/- 0.4 mm valved conduit) with a peak pressure gradient of 26.2 +/- 1.9 mmHg and no or trivial valvular regurgitation.
CONCLUSIONS: The Biovalsalva prosthesis should be considered for patients requiring a biological aortic root replacement. It offers an "off-the-shelf" preassembled composite biological valve conduit with excellent hemostatic and hemodynamic properties.
Authors:
Narain Moorjani; Amit Modi; Kavita Mattam; Clifford Barlow; Geoffrey Tsang; Marcus Haw; Steven Livesey; Sunil Ohri
Related Documents :
19521996 - Transcatheter aortic valve closure to treat severe aortic regurgitation in a patient fa...
21187156 - Association of ex vivo vascular and bronchial dysfunctions in smokers.
8398186 - Pulmonary autograft valve replacement in the dilated and asymmetric aortic root.
21431476 - Debate over patient-centered care: percutaneous coronary intervention or coronary arter...
24127476 - Pulmonary capillaritis in monozygotic twin boys.
20006506 - The perforating branches of the p1 segment of the posterior cerebral artery.
Publication Detail:
Type:  Comparative Study; Journal Article     Date:  2010-02-26
Journal Detail:
Title:  Journal of cardiac surgery     Volume:  25     ISSN:  1540-8191     ISO Abbreviation:  J Card Surg     Publication Date:  2010 May 
Date Detail:
Created Date:  2010-06-11     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8908809     Medline TA:  J Card Surg     Country:  United States    
Other Details:
Languages:  eng     Pagination:  321-6     Citation Subset:  IM    
Affiliation:
Wessex Cardiothoracic Centre, Southampton General Hospital, Southampton, United Kingdom. narain.moorjani@doctors.org.uk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Beating heart valve surgery in patients with low left ventricular ejection fraction.
Next Document:  Ultrasonic scalpel for hemostasis in pacemaker-dependent patients during open-heart surgery.